Physician profile
Eveline Yawei Wu
NPI 1770630584
$136,160.97
in general payments reported to CMS, 2019-2025
15 companies · $29K in 2025
The $29K reported for 2025 was more than what 94% of Allergy providers received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,673 · 2020: $7,651 · 2021: $5,000 · 2022: $12K · 2023: $44K · 2024: $37K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $77K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $15K · Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,500.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,250.00 |
| Travel and Lodging | $14,978.10 |
| Food and Beverage | $1,281.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $126,308.11 | 2020-2025 | Joenja |
| Sumitomo Pharma America, INC. | $7,795.72 | 2023 | Rethymic |
| Astrazeneca Uk Limited | $1,511.57 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $130.50 | 2020 | |
| Abbvie INC. | $125.00 | 2019 | |
| Sobi, INC | $122.88 | 2022 | |
| Adma Biomanufacturing LLC | $111.04 | 2025 | |
| Genentech USA, INC. | $36.12 | 2019 | |
| Merck Sharp & Dohme LLC | $20.03 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eveline Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.